Clinical Trial Update: Prospective Identification of Cardiac Amyloidosis by Cardiac Magnetic Resonance Imaging

View source ↗

Summary

A clinical trial studying prospective identification of cardiac amyloidosis using cardiac magnetic resonance imaging has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Cardiomyopathy

Snippet

Sponsor: University of Cincinnati | Conditions: Amyloidosis, Paraproteinemias | Status: WITHDRAWN